Boston Financial & Equity Corporation
6
21M
5
0.11
0.17
4
- Areas of investment
Summary
Boston Financial & Equity Corporation appeared to be the VC, which was created in 1968. The main department of described VC is located in the Boston. The fund was located in North America if to be more exact in United States.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2003. The top amount of exits for fund were in 2003.
Among the most popular fund investment industries, there are Innovation Management, Medical Device. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Angiolink Corporation. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Boston Financial & Equity Corporation, startups are often financed by Bioventures Investors. The meaningful sponsors for the fund in investment in the same round are Bioventures Investors, JHK Investments, IDP Industrial Development Partners. In the next rounds fund is usually obtained by JHK Investments, IDP Industrial Development Partners, Bioventures Investors.
The overall number of key employees were 1.
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 0
- Exits
- 4
- Rounds per year
- 0.11
- Follow on index
- 0.17
- Investments by industry
- Medical (2)
- Health Care (2)
- Biotechnology (2)
- Medical Device (2)
- Innovation Management (2) Show 13 more
- Investments by region
-
- United States (6)
- Peak activity year
- 2020
- Number of Unicorns
- 3
- Number of Decacorns
- 3
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Avg. valuation at time of investment
- 2B
- Group Appearance index
- 0.67
- Avg. company exit year
- 6
- Avg. multiplicator
- 37.68
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Angiolink Corporation | 10 Sep 2003 | Biotechnology, Health Care, Medical Device, Medical, Innovation Management | Early Stage Venture | 13M | United States, Massachusetts, Taunton |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.